Cessatech A/S (NGM:CESSA)
Sweden flag Sweden · Delayed Price · Currency is SEK · Price in DKK
14.38
+0.08 (0.56%)
At close: May 12, 2025
138.87%
Market Cap 365.77M
Revenue (ttm) 3.82M
Net Income (ttm) -22.54M
Shares Out 17.43M
EPS (ttm) -1.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,450
Average Volume 37,282
Open 14.50
Previous Close 14.30
Day's Range 13.84 - 14.50
52-Week Range n/a
Beta 0.57
RSI 66.11
Earnings Date Apr 24, 2025

About Cessatech

Cessatech A/S, a pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark. The company’s lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for sedative procedures for children from 0-17 years of age; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S... [Read more]

Industry Pharmaceutical Preparations
Founded 2020
Employees 4
Stock Exchange Nordic Growth Market
Ticker Symbol CESSA
Full Company Profile

Financial Performance

Financial numbers in DKK Financial Statements

News

There is no news available yet.